Mpox and Smallpox Threats: Vaccine Development and Biosecurity Policy ...

We recently published a list of 10 Stocks Fall Behind Amid Market Optimism. In this article, we are going to take a look at ...

Tonix Pharmaceuticals Holding Corp.’s TNXP share price has dipped by 10.75%, which has investors questioning if this is right ...

Tonix is a fully integrated biopharmaceutical company focused on transforming therapies for pain management and vaccines for public health challenges. Tonix’s development portfolio is focused on ...

Tonix Pharmaceuticals (NASDAQ: TNXP) , a fully-integrated biopharmaceutical company with commercial products and a robust development pipeline, will ...

CHATHAM, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and ...

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.

In this article, we are going to take a look at where Tonix Pharmaceuticals Corp. (NASDAQ:TNXP) stands against other stocks that fall behind amid market optimism. Wall Street’s main indices ...

Tonix Pharmaceuticals (TNXP) announced a collaborative research agreement under which Tonix and Makana will study Tonix’s anti-CD40L monoclonal ...

Tonix Pharmaceuticals has submitted an NDA for its candidate TNX-102 SL for fibromyalgia, with a PDUFA date set for August 15, 2025. Despite positive pivotal study data, Tonix faces significant ...